PF-03814735, Catalog: B1257

IN STOCK!

US$0.00

Quantity

N-[2-[(1S,4R)-6-[[4-(cyclobutylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino]-1,2,3,4-tetrahydronaphthalen-1,4-imin-9-yl]-2-oxoethyl]-acetamide; Aurora kinase A and B inhibitor

PRODUCT SUMMARY

Alternate Name (2S,4aR,5S,8R,8aR)-8-Ethyl-4a,5-dihydroxy-hexahydro-2H-2,5-epoxychromen-4(3H)-one

Appearance Amorphous solid

CAS # 144096-48-0

Molecular Formula C₁₁H₁₆O₅

Molecular Weight 228.2

Purity ≥ 98% by HPLC

Solubility DMSO

SMILES O=C1C[C@@](O2)([H])O[C@]3([H])[C@H](CC)CC[C@@]2(O)[C@]13O

InChi O InChI=1S/C11H16O5/c1-2-6-3-4-10(13)11(14)7(12)5-8(16-10)15-9(6)11/h6,8-9,13-14H,2-5H2,1H3/t6-,8+,9-,10+,11+/m1/s1

InChi Key NJLUHFDDAQPMDI-GSLIMFEQSA-N

Storage Conditions -20°C

Shipping Conditions Gel Pack

USAGE For Research Use Only! Not For Use in Humans.

Handling Do not take it internally. Wear a glove and mask when handling the product. Protect from air and moisture.

DESCRIPTION

Agistatin E is a tricyclic analog of Agistatin A. Acts as a cholesterol biosynthesis inhibitor. Mycotoxin.